CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum

Wenzhi Shen,Xiaoyuan Zhang,Jiaping Tang,Zhixin Zhang,Renle Du,Dehong Luo,Xiaoran Liu,Yong Xia,Yanping Li,Shanshan Wang,Siyuan Yan,Wancai Yang,Rong Xiang,Na Luo,Yunping Luo,Jianjun Li
DOI: https://doi.org/10.7150/thno.62534
IF: 11.6
2021-01-01
Theranostics
Abstract:[This corrects the article DOI: 10.7150/thno.51000.].
medicine, research & experimental
What problem does this paper attempt to address?